Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments

    NEXT STORY
    BioNTech Completes Acquisition of Neon Therapeutics
    PREV STORY
    Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    SANOFI TO ACQUIRE ABLYNX FOR €3.9 BILLION

    Regulated information - inside information Strengthens Sanofi's R&D strategy with innovative Nanobody® technology platform ...

    author_avatar
    NASDAQ Market News

    Phase 3 Results of Bavarian Nordic’s Smallpox Vaccine Published in The New England Journal of Medicine

    author_avatar
    NASDAQ Market News

    Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

    BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP), a biotechnology company ...

    author_avatar
    NASDAQ Market News